SynthesisBMC cancer2024

CD19 CAR T cells for B cell malignancies: a systematic review and meta-analysis focused on clinical impacts of CAR structural domains, manufacturing conditions, cellular product, doses, patient's age, and tumor types.

Erik Montagna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.